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The gastrointestinal (GI) tract is a major site of disease in HIV infection: almost half of HIV-infected patients present with GI
symptoms,andalmostallpatients developGI complications.GIsymptoms suchas anorexia,weightloss,dysphagia,odynophagia,
abdominal pain, and diarrhea are frequent and usually nonspeciﬁc among these patients. Endoscopy is the diagnostic test of
choice for most HIV-associated GI diseases, as endoscopic and histopathologic evaluation can render diagnoses in patients
with non-speciﬁc symptoms. In the past three decades, studies have elucidated a variety of HIV-associated inﬂammatory,
infectious, and neoplastic GI diseases, often with speciﬁc predilection for various sites. HIV-associated esophageal disease,
for example, commonly includes candidiasis, cytomegalovirus (CMV) and herpes simplex virus (HSV) infection, Kaposi’s
sarcoma (KS), and idiopathic ulceration. Gastric disease, though less common than esophageal disease, frequently involves CMV,
Mycobacterium avium-intracellulare (MAI), and neoplasia (KS, lymphoma). Small bowel biopsies and intestinal aspirates from
HIV-infected patients often show HIV enteropathy, MAI, protozoa (Giardia, Isospora, Cryptosporidia, amebae, Microsporidia),
and helminths (Strongyloides stercoralis). Colorectal biopsies demonstrate viral (CMV, HSV), bacterial (Clostridia, Salmonella,
Shigella, Campylobacter), fungal (cryptococcosis, histoplasmosis), and neoplastic (KS, lymphoma) processes. Herein, we review
HIV-associated GI pathology, with emphasis on common endoscopic biopsy diagnoses.
1.Introduction
In 2004, the World Health Organization (WHO) identiﬁed
HIV/AIDS as the world’s most urgent public health chal-
lenge, as AIDS represents the greatest lethal epidemic in
recent history. The gastrointestinal (GI) tract is a major
site of disease in HIV infection: almost half of all HIV-
infected patients present with GI symptoms, and almost all
patients develop GI complications [1]. GI symptoms, such
as anorexia, weight loss, dysphagia, odynophagia, abdominal
pain, and diarrhea, are common and usually non-speciﬁc in
this population. Endoscopy is the diagnostic test of choice
for most HIV-associated GI diseases, as endoscopic and
histopathologic evaluation can render diagnoses in patients
with non-speciﬁc symptoms.
Pathologic evaluation of endoscopic biopsy speci-
mens includes light and electron microscopy, special
stains, immunohistochemical techniques, ﬂuorescent in situ
hybridization (FISH), and polymerase chain reaction (PCR)
[2]. Light microscopy, with hematoxylin and eosin (H
& E) staining, is often suﬃcient to suggest or conﬁrm
a diagnosis. Electron microscopy may be used to identify
protozoan infections of the small bowel, as small organisms
such as Cryptosporidia and microsporidia are more readily
apparent with this technique. Special stains can be used to
highlight speciﬁc disease characteristics: periodic acid-Schiﬀ
with diastase (PASD) stains highlight acid mucopolysaccha-
rides, glycogen, and pseudohyphae in candidiasis; Grocott’s
methenamine silver (GMS) stains reveal fungal elements
such as Candida, Histoplasmosis, and Cryptococcus;a c i d -
fast bacilli (AFB) stains demonstrate mycobacterial bacilli,
as in mycobacterium avium-intarcellulare (MAI) infection;
Warthin-Starry stains are used for spirochetes; and Brown-
Brenn stains aid in the diagnosis of microsporidia. Immuno-
histochemistry, FISH, and PCR are valuable tools to identify
viral infections—such as cytomegalovirus (CMV) or herpes2 Pathology Research International
simples virus (HSV)—and HIV-associated neoplasia in
tissue samples.
Herein, we review HIV-associated GI pathology, with
emphasis on common endoscopic biopsy diagnoses.
2.Materialsand Methods
We reviewed the current medical literature. Images were
selected from archives in the Departments of Pathology and
Gastroenterology at a large academic hospital.
3.Resultsand Discussion
3.1. Upper GI Pathology (Tables 1 and 2;F i g u r e s1 and
2). Deﬁnitive diagnosis of HIV-associated esophageal dis-
eases requires upper endoscopy with biopsy, as the most
common esophageal lesions include candidiasis, CMV and
HSV infections, and idiopathic ulceration. Endoscopically,
candidiasis appears as white or yellow plaques with sur-
rounding mucosal erythema, on otherwise intact esophageal
mucosa (Figure 1). The plaques are usually discrete, but
may become conﬂuent and/or circumferential. Esophageal
ulceration suggests concomitant viral infection (such as
CMV or HSV) [3]. Histopathologic features of candidiasis
include pseudomembranes and neutrophilic inﬁltrates; the
fungi appear as budding yeast forms and pseudohyphae
(Figure 2).
CMV is the most common opportunistic agent in HIV-
infected patients, and, while it can aﬀect the entire GI
tract, it frequently involves the esophagus and the colon [4].
CMV typically presents with distal esophageal ulceration,
which may range from small, discrete, and superﬁcial to
extremely large anddeep,such thatonly infected granulation
tissue is evident (Figure 1). Rarely, CMV may present as a
mass lesion, or inﬂammatory pseudotumor, causing luminal
obstruction. CMV-infected cells are enlarged (10–15µm),
with strongly eosinophilic nuclear inclusions, which are
surrounded by a clearhalo, and small basophilic cytoplasmic
inclusions; these cytoplasmic inclusions cause a granular
appearance under light microscopy (Figure 2)[ 2]. Infected
and dead cells may appear mummiﬁed and enlarged, but
without nuclear inclusions. Biopsies from the ulcer base are
more likely to demonstrate characteristic CMV inclusions,
which are usually seen in stromal and endothelial cells, as
compared to HSV infection, which manifests in squamous
cells [3]. Necrotizing vasculitis and regenerative mucosal
hyperplasia may also be present (Figure 2)[ 2]. Immuno-
histochemistry, FISH, and PCR are ancillary to microscopic
diagnosis and oﬀer greater sensitivity in latent infection.
Endoscopic features of HSV infection include vesicu-
lation and ulceration; the latter are round, multiple, well
circumscribed, uniform, and smaller than those in CMV
disease (Figure 1). Histopathologic features of HSV are
more evident in biopsies from ulcer edges, as opposed
to ulcer bases, and include necrosis, acute and chronic
inﬂammation, and diagnostic nuclear changes (Figure 2).
HSVcytopathiceﬀectencompasses (i)homogenousground-
glass nuclei with margination of chromatin, (ii) nuclear
molding, (iii) multinucleation, and, rarely, (iv) Cowdry type
A nuclear inclusions [5]. Moreover, HSV-induced ulceration
exhibits an inﬂammatory inﬁltrate rich in neutrophils and
histiocytes, the presence of which should prompt a thorough
search for viral cytopathic changes [2].
HIV-associated idiopathicesophagealulcerationrefers to
large, irregular, mid esophageal and distal esophageal ulcers
with no identiﬁableetiologic agent.These ulcersare typically
associated with severe odynophagia and weight loss, but
often respond to corticosteroid and/or thalidomide ther-
apy [3]. Endoscopically, idiopathic ulcers resemble CMV-
induced ulcers, but are more often solitary and deep [6].
Biopsy reveals a nonspeciﬁc mixed inﬂammatory inﬁltrate,
with prominent eosinophils and granulation tissue [5].
Other esophageal diseases in HIV-infected patients include
gastroesophageal reﬂux disease (GERD) with esophagitis or
peptic strictures, pill-induced esophagitis, carcinoma, tuber-
culosis, histoplasmosis, cryptosporidiosis, Kaposi’s sarcoma,
and Pneumocystis infection [3].
Many opportunistic GI diseases have decreased in
frequency since the introduction of eﬀective antiretrovi-
ral therapy, but Helicobacter pylori infection and GERD
have apparently increased in frequency [7]. This may be
attributed, in part, to alleviation of the gastric hypochloridia
often seen in severely immunocompromised patients.
While upper GI symptoms, such as epigastric pain,
nausea, and vomiting, are often reported by HIV-infected
patients, gastric disease is relatively uncommon [3]. In HIV-
infected patients, CMV is the most frequent opportunistic
gastric infection and may be the most commonly identiﬁed
cause of ulcer disease in symptomatic patients [8, 9].
Endoscopically, CMV gastritis appears as patchy erythema,
erosions, or multiple small ulcers. Unlike intestinal biopsy
specimens, gastric biopsies often show CMV inclusions in
epithelial cells. CMV-infected cells are markedly enlarged
with amphophilic nuclear inclusions and abundant granular
basophilic cytoplasm (Figure 2)[ 5].
Mycobacterium-avium intracellulare (MAI) is the most
common mycobacterial infection in severely immunocom-
promised patients, and disseminated infection often causes
mesenteric lymphadenitis with diﬀuse abdominal pain,
weight loss, fever, or diarrhea. Endoscopically, MAI com-
monly presents with multiple raised nodules or normal-
appearing mucosa. Less common ﬁndings include ulcer-
ation, erythema, edema, friability, reduced mucosal vas-
cularity, stricture, and aphthous erosions [10]. Deﬁnitive
diagnosis is established by biopsy, with demonstration of
acid-fast bacilli in tissue specimens; blood and stool cultures
mayalsorevealMAIinfection[3].Antimycobacterialtherapy
forMAIisprolongedandcanbecomplicatedbyadversedrug
eﬀects.
In addition to opportunistic infections, gastric neoplasia
may be diagnosed on biopsies: Kaposi’s sarcoma (KS) and
non-Hodgkin’s lymphoma frequently aﬀect the stomach.
Gastrointestinal Kaposi’s sarcoma is often asymptomatic,
but gastric involvement may result in pyloric obstruc-
tion, pain, or upper GIT bleeding [3]. Endoscopically,
KS appears as submucosal violet-red nodules, plaques, or
polyps. Its subtle, submucosal presentation often resultsPathology Research International 3
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 1: Endoscopic features of HIV-associated GI pathology. (a, b) Esophageal candidiasis: creamy mucosal plaques, (c) esophageal
ulceration,(d)duodenalgiardiasis,(e)intestinalcryptosporidiosis,withgranular,friablemucosa,(f)ileallymphoidhyperplasia,(g)bacterial
colitis, (h) colonic ulceration, and (i) proctitis.
in false-negative endoscopic biopsy results. Histologically,
KS is composed of spindle cells and irregular, jagged, slit-
like spaces lined by atypical endothelial cells; extravasated
red cells, hemosiderin, and eosinophilic round cytoplasmic
globules are also often evident (Figure 2)[ 5]. Moreover,
human herpesvirus 8 (HHV8) immunostains may aid in
diagnosis, as the virus has been implicated in the patho-
genesis of KS. In contrast to KS, gastric lymphoma is
frequently symptomatic, as it is typically advanced (stage IV)
at presentation, and causes epigastric pain or symptoms of
gastric outlet obstruction [3]. The majority (95%) are B-cell
lymphomas—usually immunoblastic or large cell type [11]
(Figure 2)—and can be diﬃcult to distinguish from adeno-
carcinoma on endoscopy, because both entities present as
ulcerated mass lesions. Biopsy, however, facilitates deﬁnitive
diagnosis.
3.2. HIV-Associated Diarrhea. Diarrhea is themost common
GI symptom in HIV-infected patients, aﬀecting up to 90%
of patients, and increases in frequency and severity as
immune function deteriorates [12]. The most common4 Pathology Research International
HIV-associated diarrheal pathogens include Cryptosporid-
ium, nontubercular mycobacteria, microsporidia, bacteria
(Salmonella, Shigella, Campylobacter, and E. coli), and CMV
[13].
AIDS-related diarrhea results from numerous etio-
logic agents and pathophysiologic mechanisms [14]. HIV
enteropathy, for example, causes ileal dysfunction, altered
bowel motility, and bacterial overgrowth. Direct HIV infec-
tion of intestinal mucosa results in chronic inﬂammation,
infection of enterochromaﬃn cells, gp120 interation with
VIP receptors, antiproliferative eﬀects, and enterocyte dys-
function. MAI leads to an exudative enteropathy and altered
secretion of inﬂammatory mediators (e.g., interleukin-1).
C. diﬃcile also alters secretion of IL-1. Cryptosporidium,
microsporidia, and Isospora cause diarrhea by decreasing the
mucosal surface area.
Despite the controversial role of bidirectional endoscopy
in the evaluation of HIV-associated diarrhea, the following
diagnostic algorithm has been suggested: in patients with
diarrhea, a CD4 count less than 100/mm3 and inconclusive
routine stool studies, the best overall diagnostic test is
colonoscopy with terminal ileal intubation and biopsy;
in patients with CD4 counts of 100–200/mm3 ,ﬂ e x i b l e
sigmoidoscopy and biopsy are suﬃcient, because CMV
infection is less likely to occur at higher CD4 counts [3]. If
diagnostic doubt remains, duodenal biopsies may be useful,
especiallyinpatientswithlowerCD4counts[13].Theroleof
routine stool studies for ova, parasites, and so forth—before
endoscopy and biopsy—cannot be overemphasized.
3.3. HIV-Associated Small Bowel Pathology (Tables 1 and
2;F i g u r e s1 and 2). Intestinal biopsies and aspirates from
HIV-infected patients may reveal HIV enteropathy, CMV,
MAI, protozoa (Cryptosporidium, Isospora, microsporidia,
Giardia), helminths (Strongyloides stercoralis), and fungi
(Histoplasma capsulatum)—all of which may cause malab-
sorption and/or diarrhea. The organisms most commonly
found on duodenal biopsies include CMV, Cryptosporidium,
microsporidia, and Giardia [3].
As in gastric infection (see above),CMV causesintestinal
inﬂammation, erosion, and ulceration, with characteristic
CMV inclusions in stromal and endothelial cells. Intestinal
MAI causes subtle macroscopic changes, such as thickened
or edematous mucosal folds with occasional yellow patches,
which can become conﬂuent [3]. Histopathologic features of
intestinal MAI infection mimic Whipple’s disease, as both
entities exhibit periodic acid-Schiﬀ-(PAS)-positive foamy
macrophages in the lamina propria: in MAI, however, the
macrophages are ﬁlled with acid-fast bacilli and villous
atrophy is often present (Figure 2)[ 5].
Small bowel protozoal infections cause irregular, fused,
widely-spaced, shortened villi, resulting in an erythematous,
granular appearance on endoscopy (Figure 1)[ 5]. Cryp-
tosporidia are small (2–5µm), round, basophilic organisms,
which appear on the luminal borders of enterocytes, sub-
mucosal glands, and ducts on light microscopy (Figure 2);
surrounding villi are variably atrophic, with infrequent crypt
abscesses and neutrophils in the lamina propria. Both Cryp-
tosporidia and microsporidia are often missed on routine
biopsies, as their subtleappearance isbetterappreciated with
electron microscopy. If microsporidia spores are not iden-
tiﬁed in stool samples or duodenal aspirates, Brown-Brenn
stains may aid in visualization. Moreover, microsporidia can
be reliably diagnosed using a modiﬁed trichrome stain, PCR
analysis of stool specimens, or FISH. Enteric isosporiasis,
secondary to opportunistic Isospora belli infection, is more
c o m m o ni nH I V - i n f e c t e dp a t i e n t si nd e v e l o p i n gc o u n t r i e s
than in the United States or in Europe. Isosporiasis localizes
to the small bowel, but can spread to the colon and regional
lymph nodes. Diagnosis is facilitated by identiﬁcation of
(i) oocysts in stool samples or duodenal aspirates, or (ii)
merozoites on light or electron microscopy.
Giardia lamblia is a ﬂagellated enteric protozoan, which
is typically waterborne, but is also transmitted person-to-
person through fecal-oral spread [2, 15]. Giardia causes
acute and chronic diarrhea worldwide; in the USA, it is
the most commonly identiﬁed intestinal parasite. Acute
giardiasis causes diarrhea, cramps, bloating, and ﬂatulence;
chronic infection results in malabsorption, steatorrhea,
malaise, weight loss, and diﬀuse abdominal discomfort.
Initially transmitted as a cyst, Giardia forms a trophozoite
that adheres to intestinal epithelium. The trophozoites are
pearshaped and binucleate, but may appear sickle-shaped
in sagittal sections, and mistaken for detached enterocytes
(Figure 2). Identiﬁcation of cysts or trophozoites in the
stool conﬁrms the diagnosis of giardiasis. In the absence of
cysts of trophozoites in stool specimens, upper endoscopy
and duodenal biopsy may conﬁrm the diagnosis. Giardia’s
pathogenicity is inﬂuenced by cellular and humoral immune
responses, and certain immunodeﬁciencies—such as HIV
infection—predispose to giardiasis. HIV-infected patients
show a decreased antibody response to Giardia, but their
clinical manifestations are similar to those of immunocom-
petent hosts [15]. Metronidazole is eﬀective in the treatment
of giardiasis, but is not recommended for pregnant patients
due to potential teratogenicity.
Strongyloides stercoralis is a parasitic nematode with a
predilection for the small intestine [2]. Intestinal lesions can
be divided into three morphologic categories: (i) catarrhal
enteritis, in which the small bowel appears congested
with abundant mucus secretion, petechial hemorrhages,
and submucosal mononuclear inﬂammation; (ii) edematous
enteritis, in which the bowel wall is thickened, the mucosal
folds are ﬂattened, and the submucosa shows edema and
inﬂammation; (iii) ulcerative enteritis, in which the bowel
wall is rigid, ﬁbrotic, and ulcerated, with abundant neu-
trophilic inﬁltrates.
HIV enteropathy often causes severe malabsorption, lac-
tose intolerance, vitamin B12 and D-xylose malabsorption,
and increased intestinal permeability with protein loss [3].
While the pathophysiology of HIV enteropathy-induced
diarrhea remains unclear, there are currently two hypotheti-
cal mechanisms: (i) mucosal HIV infection aﬀects intestinal
permeability by disrupting tight junctions, epithelial apop-
totic activity, or both [16]; (ii) coupled with a coreceptor,
HIV protein gp120 causes calcium-mediated microtubulePathology Research International 5
Table 1: HIV-associated GI pathology: commonbiopsy diagnoses.
Pathologic process Esophagus Stomach Small bowel Colorectal
Inﬂammatory/Ulcerative Idiopathic
Pill-induced Nonspeciﬁc gastritis HIV enteropathy HIV enteropathy
Idiopathic
Viral infection CMV CMV CMV CMV
HSV HSV
MAI MAI Clostridium diﬃcile
Salmonella
Bacterial infection — Shigella
Campylobacter
Spirochetosis
Giardia lamblia
Cryptosporidia
Protozoan and Helminthic
infections — Cryptosporidia Isospora belli
Microsporidia
Strongyloides stercoralis
Candida albicans Cryptococcus neoformans Histoplasma capsulatum Cryptococcus neoformans
Fungal infection Candida krusei
Candida tropicalis Histoplasma capsulatum
Torulopsis glabrata
Neoplastic Kaposi’s sarcoma Kaposi’s sarcoma NHL Kaposi’s sarcoma Kaposi’s sarcoma NHL
Key: HIV: human immunodeﬁciency virus, CMV = cytomegalovirus, HSV = herpes simplex virus, MAI = mycobacterium avium-intracellulare,N H L= non-
Hodgkin lymphoma.
loss and cellular instability results [17]. Endoscopically,
HIV enteropathy may manifest as “frosted” mucosa [3];
histopathologic changes include villous blunting and widen-
ing, vacuolated enterocytes, and increased inﬂammatory
cells in the lamina propria. Initiation of highly active
antiretroviral therapy (HAART) leads to resolution of both
clinical symptoms and ultrastructural tissue changes.
3.4. Lower GI Pathology (Tables 1 and 2;F i g u r e s1 and 2).
The endoscopic appearance of viral colitis in HIV-infected
patients is highly variable [18]. Evaluation of the colon
may reveal (i) normal mucosa, (ii) characteristic features of
viral infection (such as nuclear inclusions involving surface
epithelium), or (iii) severe ulceration (such as in CMV
colitis). CMV is the most common viral cause of diarrhea in
HIVinfectionand mayaﬀectany portionoftheGIT.InHIV-
infected patients, latent CMV reactivates, leading to viremia,
deposition of viral particles in the vascular endothelium,
and vasculitis; this culminates in submucosal ischemia and
ulceration [19]. To identify CMV colitis, colonoscopy is
preferredoverﬂexiblesigmoidoscopy,asmorethanonethird
of aﬀected patients have gross disease restricted to proximal
regions of the colon [20]. Endoscopically, CMV colitis may
appear as (i) colitis alone (with edema and subepithelial
hemorrhage), (ii) colitis with ulceration, or (iii) aggregates
of discrete ulcers (ranging from 5mm to 2cm) surrounded
by unremarkable mucosa (Figure 1)[ 21, 22]. Occasionally,
the colonic mucosa may appear granular and friable, as
in ulcerative colitis, or the patient may present with an
abdominal mass [18].
CMV colitis is diagnosed by identiﬁcation of typical
inclusion bodies in biopsy specimens (see above) [18].
Serologic studies and cultures of biopsy materials are
unnecessary. Viral inclusions are most often present in the
endothelial cells of the deeper layers of the bowel wall,
thus multiple biopsies may be necessary for identiﬁcation.
Necrotizing vasculitis and endoluminal thrombosis may also
be seen. As in CMV infection elsewhere in the GI, the
etiologic role of CMV in the cellular inclusions can be
conﬁrmed by immunoperoxidase staining, FISH, or PCR.
Symptomatic treatment of CMV colitis includes intravenous
ganciclovir, foscarnet, or cidofovir, but none of these agents
improve mortality [23].
Bacterial colitis can result from (i) anomalous growth
of intestinal ﬂora, (ii) bacterial infections (including
Salmonella, Shigella, and Campylobacter), or (iii) oppor-
tunistic pathogens (such as atypical mycobacteria) [2].
Endoscopically, bacterial colitis appears as epithelial necro-
sis, abscesses, erosions, ulceration, and focal hemorrhage.
Histopathologic features of bacterial colitis include mucosal
epithelial changes: degeneration, necrosis, cellular atypia,
regeneration, and ﬁssures. The severityof immunodeﬁciency
and bacterial infection determines the degree of mucosal
damage. On H&E staining, bacterial forms appear as small,
basophilic cocci, bacilli, or coccobacilli. MAI may also aﬀect
thecolon,causingdiarrhea,malabsorption,ﬂattenedmucosa
on endoscopicexamination, and a dense histiocytic inﬁltrate6 Pathology Research International
Table 2: Endoscopic and histopathologicfeatures of commonHIV-associated GI diseases [2].
Viral infections Bacterial infections Protozoal and
Helminthic infections Fungal infections Neoplastic processes
Endoscopy
(Figure 1)
Erythema, vesiculation,
erosion, ulceration
Hyperemia, ulceration,
inﬂammatory
pseudopolyps
Normal to atrophic
mucosa
Creamy mucosal
patches, ulceration,
mycotic abscesses
Mucosal and
submucosalmass
lesions
Histopathology
(Figure 2)
Viral cytopathic eﬀects,
inﬂammatory
inﬁltrates, necrotizing
vasculitis
Mucosal epithelial
degeneration, loss of
intestinal microvilli,
cytologic atypia,
epithelial ﬁssures,
inﬂammatory
inﬁltrates, abundant
foamy macrophages
(MAI)
Mucosal atrophy,
inﬂammatory
inﬁltrates, eosinophilia
(Isospora),
histiocytosis in lamina
propria (Leishmania)
Cell necrosis,
pseudomembranes,
hyphae penetrating
intact mucosa and
vasculature
KS: spindle cell
neoplasms with
irregular slit-like
spaces; NHL: dense
proliferation of
uniform, small, round,
cells
in the lamina propria. In this setting, Crohn’s disease may
be considered in the diﬀerential diagnosis. As in upper GI
MAI infection, acid-fast staining will reveal mycobacterial
organisms.
HIV-related cryptococcosis commonly aﬀects the colon
and the esophagus, while the stomach and terminal ileum
are rarely involved [24]. Endoscopically, Cryptococcus infec-
tion causes destructive cysts composed of fungal masses.
Histopathologic features include fungal colonies of spher-
ical to oval yeast-like pleomorphic cells, which are often
surrounded by a clear halo corresponding to the mucinous
capsule (Figure 2). Mucicarmine, Alcian blue, and GMS
stains facilitate identiﬁcation of fungal forms.
Histoplasmosis is the most common endemic mycosis
in HIV-infected patients; this population is also more likely
to experience disseminated infection [25]. Despite frequent
GI involvement, the symptoms are typically non-speciﬁc
or absent [26, 27]. Previous studies of HIV-associated GI
histoplasmosis report fever and abdominal pain in 70% of
patients, and weight loss and diarrhea in less than 50%
[26,27].GIbleeding,obstruction,perforation,andstrictures
are rare. In HIV-infected patients, histoplasmosis is most
likelytoaﬀecttheileocecalregion,withmarkedmorphologic
heterogeneity [28]. The following pathologic features may
be seen: (i) grossly unremarkable mucosa, despite marked
histiocytic inﬁltration of the lamina propria, (ii) infected
macrophages causing plaques and pseudopolyps, and (iii)
ulceration with tissue necrosis. GMS staining often high-
lights the fungal elements (Figure 2).
In HIV infection and men who have sex with men,
proctitis may occur secondary to HSV, Neisseria gonorrhea,
Chlamydia trachomatis, or Treponema pallidum infection
[29].HSVproctitispresentswithanorectal burning,pruritis,
tenesmus, diarrhea, constipation, mucoid or bloody stools,
and/or bilateral tender inguinal lymphadenopathy [30]. Ap-
proximately1–3weeksafterinitialinfection,multiplevesicles
erupt on the perineum and in the anal canal and rectum;
these vesicles evolve into aphthous ulcers (Figure 1)[ 18].
Endoscopically, small single or grouped vesicles surrounded
by erythema are seen in the distal 5–10cm of the rectum;
these vesicles eventually coalesce to form aphthous ulcers.
Rectal biopsies may reveal typical intranuclear inclusion
bodies or multinucleated giant cells. As in CMV infection,
viral culture is rarely necessary. Symptomatic treatment
includes sitz baths, topical anesthetics, oral analgesia, and
antiviral agents (such as acyclovir, valacyclovir, and famci-
clovir) [30].
3.5. HIV-Associated GI Bleeding. With increasing immuno-
suppression, HIV-infected patients with GI bleeding may
have unique lesions related to HIV disease and should
be evaluated endoscopically [3]. Kaposi’s sarcoma and
gastroduodenal lymphoma are the most common causes of
HIV-related upper GI bleeding in advanced HIV infection.
Upper endoscopy with biopsy facilitates diagnosis of both
entities, and endoscopic therapy may temporarily control
bleeding, butthe deﬁnitive therapy isoften surgical resection
[3]. Lower GI bleeding in advanced HIV infection may
result from CMV colitis or Kaposi’s sarcoma [3]. Anorectal
bleeding may be secondary to condylomata, HSV, idiopathic
ulceration, and non-Hodgkin’s lymphoma [3].
4.Conclusions
Despite widespread use of HAART in HIV infection, the
GI tract is still frequently aﬀected by HIV-associated disease
processes. HIV-infected patients often present with non-
speciﬁc GI symptoms, and the diagnostic workup requires
consideration of both individual risk factors and common
HIV-associated GI diseases. A symptom-based approach to
diagnosis will direct clinical evaluation, with the caveat that
Occam’s razor—that is, diagnostic parsimony—frequently
does not apply in HIV-infected patients [31]. Therefore,
identiﬁcation of one pathologic entity should not forestall
the search for concomitant disease processes. Endoscopy and
biopsy, with histopathologic and microbiologic analysis, are
frequently required to identify and treat GIT disease in HIV-
infected patients.
Numerous studies overthe past three decades have eluci-
dated a variety of HIV-associated inﬂammatory, infectious,
and neoplastic diseases of the GI tract, often with speciﬁc
predilection for various sites. HIV-associated esophageal
disease, for example, commonly includes candidiasis, CMVPathology Research International 7
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
(m) (n) (o) (p)
Figure 2: Histopathologic features of HIV-associated GI pathology. (a) CMV gastritis, (b) CMV vasculitis, (c) HSV esophagitis, (d) HSV
cytopathic eﬀect, (e) Mycobacterium-avium intercellulare (acid fast stain), (f, g) cryptosporidiosis, (h) giardiasis, (i) esophageal candidiasis,
(j) candidal pseudohyphae and spores (PASD stain), (k) cryptococcosis (GMS stain), (l) histoplasmosis(GMS stain), (m) HIV enteropathy,
(n, o) Kaposi sarcoma,and (p) gastric non-Hodgkin’s lymphoma.
and HSV infection, Kaposi’s sarcoma, and idiopathic ulcera-
tion. Gastric disease, though less common than esophageal
disease, frequently involves CMV, Mycobacterium avium
intracellulare (MAI), and neoplasia (KS, lymphoma). Small
bowel biopsies and intestinal aspirates from HIV-infected
patients often show HIV enteropathy, MAI, protozoa (Gia-
rdia, Isospora, Cryptosporidia, amebae, Microsporidia),
and helminths (Strongyloides stercoralis). Colorectal biop-
sies demonstrate viral (CMV, HSV), bacterial (Clostridia,
Salmonella, Shigella, Campylobacter), fungal (cryptococco-
sis, histoplasmosis), and neoplastic (KS, lymphoma) pro-
cesses.
In future, the widespread use of eﬀective antiretroviral
therapy will likely decrease the frequency and severity of
HIV-related illnesses, and advances in medical knowledge
and technology will improve the prevention, diagnosis, and
treatment of HIV-associated GI disease.
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